Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

ACR to Lead Resolutions at June AMA House of Delegates Meeting

From the College  |  May 23, 2023

NIH Public Access Plan

Additionally, the ACR authored and will lead a resolution titled “NIH Public Access Plan” to raise awareness of possible unintended negative consequences of the planned National Institutes of Health (NIH) pathway. The resolution is cosponsored with 10 other specialty societies. The resolution, if passed, would direct the AMA to work with professional organizations, such as the ACR and other specialty societies, and Congress to raise awareness of and mitigate possible adverse consequences of the proposed NIH Public Access Plan to ensure continued equitable access to quality clinical research.

The concerns of the ACR and other specialty societies stem from changes directed in 2022 by the White House Office of Science & Technology Policy (OSTP), which established new guidance for public access to scholarly publications and data resulting from federally supported research. The OSTP directive requires that peer-reviewed scholarly publications containing any content derived from federal funding, including data on which a study is based, be made immediately available, at no cost, by the end of 2025. This reverses a 2013 policy permitting manuscripts to remain behind a subscription paywall for a one-year period before being accessible for free. The AMA previously had policy that it would work with organizations and Congress to prevent any changes to this policy that would allow public release of NIH research articles within 12 months of publication.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The groups recognize the policy’s intended benefit of making new knowledge as described in published scientific manuscripts immediately available to researchers, scientists and the lay public without a subscription, which in theory could improve efforts to replicate results and the faster application of new scientific and clinical knowledge. However, they also recognize that the NIH plan as proposed might not achieve these goals, due to several likely unintended consequences related to significant changes in business models. These include potential negative consequences in the areas of equity, quality, peer review, scientific record oversight, financial sustainability and the future of scientific research.

In particular, there are concerns the pathway as currently proposed by NIH will encourage a pay-to-publish model that may create substantial inequity in terms of who is able to contribute to the body of peer-reviewed, published scientific research. Necessary changes to business models will likely shift financial responsibility from subscribers to the researchers seeking to have their research published, creating substantial additional barriers for those seeking publication. Many researchers, including junior scientists, who often have limited funds, will find these fees prohibitive. When funds are unavailable, publishing completed work will be delayed or abandoned, hindering the dissemination of new knowledge—precisely the opposite of the desired policy goals.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 | Single Page
Share: 

Filed under:Legislation & Advocacy Tagged with:AMA House of Delegates (HOD)In-office treatmentNational Institutes of Healthresearch publishing

Related Articles

    The ACR’s Representation in American Medical Association Critical as Review Looms

    March 17, 2017

    There is a saying that if the American Medical Association (AMA) did not exist, we would have to invent it. That is just what Dr. Nathan S. Davis did back in 1845 when he called for a national medical convention and laid the foundation for the establishment of the AMA in 1847. This new group would…

    Rheumatology Priorities Advanced at Busy AMA House of Delegates Meeting

    June 16, 2023

    Two ACR-led resolutions on in-office specialty drug dispensing and the proposed NIH Public Access Plan passed the House of Delegates and will become AMA policy.

    Pointers for Rheumatologists Considering AMA Membership

    February 3, 2012

    Join the AMA. Don’t join because you agree with everything the AMA does. Join so we, as rheumatologists, will continue to have a voice and make a difference.

    Why Keep a Seat at the AMA Table?

    January 18, 2017

    As 2017 unfolds—a year when MACRA begins, lawmakers take steps to dismantle the health reform efforts of the past eight years, and political uncertainty is the rule—it is imperative that the ACR leverage its advocacy agenda by maintaining its seat at the American Medical Association’s (AMA’s) House of Delegates (HOD), says Gary Bryant, MD, FACP…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences